Literature DB >> 29181102

MicroRNA-1271 inhibits cellular proliferation of hepatocellular carcinoma.

Andong Qin1, Jiehua Zhu2, Xingxiang Liu1, Dongxiao Zeng1, Maolin Gu1, Chun Lv1.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-associated mortality worldwide, particularly in China. MicroRNAs (miRs) serve important roles in the pathogenesis of HCC. The present study investigated the function of miR-1271 in HCC. The miR-1271 levels were analyzed by quantitative reverse transcription polymerase chain reaction. Cells growth was examined by MTT assay. Bioinformatics algorithms from TargetScanHuman were used to predict the target genes of miR-1271. The protein level was assayed by western blotting. miR-1271 demonstrated a lower expression level in HCC tissues. Upregulation of miR-1271 suppressed the growth of HepG-2 and Huh-7 cells and induced apoptosis of cells. Forkhead box Q1 (FOXQ1) was targeted by miR-1271. In conclusion, miR-1271 is a novel tumor suppressor that inhibits HCC proliferation and induces cellular apoptosis by targeting FOXQ1 in HCC. The results of the present study may provide a novel therapeutic target of HCC.

Entities:  

Keywords:  cell growth; hepatocellular carcinoma; microRNA-1271; survival

Year:  2017        PMID: 29181102      PMCID: PMC5696716          DOI: 10.3892/ol.2017.7052

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  51 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 3.  Forkhead transcription factors: key players in development and metabolism.

Authors:  Peter Carlsson; Margit Mahlapuu
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

4.  microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.

Authors:  Hao Zhang; Xiaobing Cai; Yang Wang; Hao Tang; Daki Tong; Fang Ji
Journal:  Oncol Rep       Date:  2010-11       Impact factor: 3.906

5.  MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Authors:  Dong Li; Xingguang Liu; Li Lin; Jin Hou; Nan Li; Chunmei Wang; Pin Wang; Qian Zhang; Peng Zhang; Weiping Zhou; Zhengxin Wang; Guoshan Ding; Shi-Mei Zhuang; Limin Zheng; Wenzhao Tao; Xuetao Cao
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

6.  Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.

Authors:  Shunsuke Ura; Masao Honda; Taro Yamashita; Teruyuki Ueda; Hajime Takatori; Ryuhei Nishino; Hajime Sunakozaka; Yoshio Sakai; Katsuhisa Horimoto; Shuichi Kaneko
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

7.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

8.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

Authors:  Laura Gramantieri; Manuela Ferracin; Francesca Fornari; Angelo Veronese; Silvia Sabbioni; Chang-Gong Liu; George A Calin; Catia Giovannini; Eros Ferrazzi; Gian Luca Grazi; Carlo M Croce; Luigi Bolondi; Massimo Negrini
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

9.  Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs.

Authors:  David M Garcia; Daehyun Baek; Chanseok Shin; George W Bell; Andrew Grimson; David P Bartel
Journal:  Nat Struct Mol Biol       Date:  2011-09-11       Impact factor: 15.369

10.  MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma.

Authors:  Xiao Hong Peng; Hao Ran Huang; Juan Lu; Xiong Liu; Fei Peng Zhao; Bao Zhang; Shao Xiong Lin; Lu Wang; Huai Hong Chen; Xia Xu; Fan Wang; Xiang Ping Li
Journal:  Mol Cancer       Date:  2014-08-07       Impact factor: 27.401

View more
  6 in total

1.  miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis.

Authors:  Chunhui Sun; Xun Yao; Qingyu Jiang; Xiuyong Sun
Journal:  Oncol Lett       Date:  2018-06-15       Impact factor: 2.967

2.  Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection.

Authors:  Xuejun Kuang; Jiazhou Ye; Zhibo Xie; Tao Bai; Jie Chen; Wenfeng Gong; Lunan Qi; Jianhong Zhong; Liang Ma; Ningfu Peng; Bangde Xiang; Feixiang Wu; Guobin Wu; Haihong Ye; Changmiao Wang; Lunqun Li
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

Review 3.  Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review.

Authors:  Simona Gurzu; Laszlo Kobori; Decebal Fodor; Ioan Jung
Journal:  Biomed Res Int       Date:  2019-09-29       Impact factor: 3.411

4.  MicroRNA‑1271‑5p alleviates the malignant development of hepatitis B virus‑mediated liver cancer via binding to AQP5.

Authors:  Zhigang Li; Lin Ma; Lingling Di; Xutao Lin
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

5.  Retracted Article: MicroRNA-1271 modulates hepatitis B virus replication, cell proliferation and apoptosis in hepatitis B virus-related hepatocellular carcinoma by targeting SIRT1.

Authors:  Fei Tang; Fengmei Wang; Hongmin Lv; Huiling Xiang; Yi Liu; Ping Liu
Journal:  RSC Adv       Date:  2019-12-02       Impact factor: 3.361

6.  Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis.

Authors:  Huayao Li; Lijuan Liu; Jing Zhuang; Cun Liu; Chao Zhou; Jing Yang; Chundi Gao; Gongxi Liu; Changgang Sun
Journal:  Mol Genet Genomic Med       Date:  2019-08-02       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.